Commonwealth Equity Services’s Enzo Biochem, Inc. ENZ Stock Holding History

Commonwealth Equity Services’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-13,685	Closed	-$40K	–	2253
2015 Q1	$40K	Buy	+13,685	New	+$44.8K	﹤0.01%	2131

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Commonwealth Equity Services's ENZ Position: Q2 2015 in Review

Commonwealth Equity Services sold out of Enzo Biochem, Inc. (ENZ) in Q2 2015, closing a stake of 13,685 shares — an estimated $40K sold.

Commonwealth Equity Services first reported a position in ENZ in Q1 2015 and held it in 1 quarter. The position peaked at $40K in Q1 2015. 86 funds tracked by Wall St. Rank hold ENZ as of Q2 2015.

Commonwealth Equity Services reported no remaining Enzo Biochem, Inc. position as of Q2 2015 after selling out during the quarter.
Commonwealth Equity Services sold 13,685 Enzo Biochem, Inc. shares in Q2 2015, an estimated $40K.
Commonwealth Equity Services first reported a position in Enzo Biochem, Inc. in Q1 2015 and held it in 1 quarter.
Commonwealth Equity Services's Enzo Biochem, Inc. position peaked at $40K in Q1 2015.
86 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2015.

Based on Commonwealth Equity Services's 13F filing for Q2 2015, filed 28 Jul 2015.